KeyBank National Association’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,252
| Closed | -$230K | – | 1092 |
|
|
2021
Q2 | $230K | Buy |
+1,252
| New | +$230K | ﹤0.01% | 1009 |
|
|
2018
Q1 | – | Sell |
-2,046
| Closed | -$245K | – | 1099 |
|
|
2017
Q4 | $245K | Sell |
2,046
-2,698
| -57% | -$323K | ﹤0.01% | 931 |
|
|
2017
Q3 | $666K | Sell |
4,744
-128
| -3% | -$18K | ﹤0.01% | 698 |
|
|
2017
Q2 | $593K | Buy |
4,872
+171
| +4% | +$20.8K | ﹤0.01% | 757 |
|
|
2017
Q1 | $570K | Sell |
4,701
-193
| -4% | -$23.4K | ﹤0.01% | 778 |
|
|
2016
Q4 | $599K | Sell |
4,894
-188
| -4% | -$23K | ﹤0.01% | 762 |
|
|
2016
Q3 | $623K | Sell |
5,082
-422
| -8% | -$51.7K | ﹤0.01% | 755 |
|
|
2016
Q2 | $643K | Buy |
5,504
+168
| +3% | +$19.6K | ﹤0.01% | 701 |
|
|
2016
Q1 | $743K | Buy |
5,336
+193
| +4% | +$26.9K | ﹤0.01% | 657 |
|
|
2015
Q4 | $981K | Sell |
5,143
-360
| -7% | -$68.7K | 0.01% | 573 |
|
|
2015
Q3 | $861K | Buy |
5,503
+247
| +5% | +$38.6K | 0.01% | 631 |
|
|
2015
Q2 | $950K | Sell |
5,256
-33
| -0.6% | -$5.97K | 0.01% | 628 |
|
|
2015
Q1 | $917K | Sell |
5,289
-174
| -3% | -$30.2K | 0.01% | 666 |
|
|
2014
Q4 | $1.01M | Sell |
5,463
-362
| -6% | -$67K | 0.01% | 624 |
|
|
2014
Q3 | $966K | Sell |
5,825
-4,076
| -41% | -$676K | 0.01% | 639 |
|
|
2014
Q2 | $1.55M | Sell |
9,901
-326
| -3% | -$50.9K | 0.01% | 505 |
|
|
2014
Q1 | $1.56M | Sell |
10,227
-2,704
| -21% | -$411K | 0.01% | 494 |
|
|
2013
Q4 | $1.72M | Buy |
12,931
+194
| +2% | +$25.8K | 0.01% | 461 |
|
|
2013
Q3 | $1.48M | Sell |
12,737
-410,953
| -97% | -$47.8M | 0.01% | 495 |
|
|
2013
Q2 | $39.5M | Buy |
+423,690
| New | +$39.5M | 0.15% | 176 |
|